MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1470-1476

  Defres, S ^a   Marwick, C ^b   Nathwani, D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Community acquired pneumonia; Healthcare associated; Hospital acquired pneumonia; Lung infections; Methicillin resistant Staphylococcus aureus; Pulmonology

Indexed keywords

TOXIC SHOCK SYNDROME TOXIN 1;

ABSCESS DRAINAGE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NECROTIZING PNEUMONIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HOSPITALIZATION; HOSPITALS; HUMANS; LUNG; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, BIOLOGICAL; PNEUMONIA; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 73249148504     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00122309     Document Type: Review

References (51)

1. Gould JC, McKillop E. The carriage of Staphylococcus pyogenes var aureus in the human nose. J Hygiene 1954; 52: 304-310.
2. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. CID 2008; 46: Suppl. 5, S350-S359.
3. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infec Immun 2007; 75: 1040-1044.
4. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130-1133.
5. Bubeck Wardenburg J, Bae T, Otto M, et al. Poring over pores: α-haemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13: 1405-1406.
6. DeLeo FR, Otto M. Antidote for Staphylococcus aureus pneumonia?J Exp Med 2008; 205: 271-274.
7. Low DE. Resistance issues and treatment implications: pneumococcus, Staphylococcus aureus and gram-negative rods. Infect Dis Clin North America 1998; 12: 613-630.
8. Said-Salim B, Mathema B, Kreiswirth BN. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 2003; 4: 451-455.
9. Deresinski S. Meticillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40: 562-573.
10. Cookson BD. Meticillin-resistant Staphylococcus aureus in the community: new battlefronts, or are the battles lost? Infect Control Hosp Epidemiol 2000; 21: 398-403.
11. Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5: 275-286.
12. Salgado CD, Farr BM, Calfee DP. Community-acquired meticillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-139.
13. Centers for Disease Control and PreventionFour pediatric deaths from community-acquired meticillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep 1999; 48: 707-710.
14. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired meticillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-598.
15. Genestier AL, Michallet MC, Prevost G, et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005; 115: 3117-3127.
16. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in immunocompetent patients. Lancet 2002; 359: 753-759.
17. Nathwani D, Morgan M, Masterton RG, et al. Guidelines for UK practice for the diagnosis and management of meticillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chem 2008; 61: 976-994.
18. American Thoracic Society, Infectious Diseases Society of AmericaGuidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
19. Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chem 2008; 62: 5-32.
20. Kollef MH. Healthcare associated pneumonia. Not just a US phenomenon. Chest 2009; 135: 594-596.
21. Shorr AF, Zilberberg MD, Micke ST, et al. Prediction of infection due to antibiotic resistant bacteria by select risk factors for healthcare - associated pneumonia. Arch Intern Med 2008; 168: 2205-2210.
22. Lim WS, Macfarlance JT. A prospective comparison of nursing home pneumonia with community acquired pneumonia. Eur Respir J 2001; 18: 362-368.
23. Rubenstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46: Suppl. 5, S378-S385.
24. Stralin K, Soderquist B. Staphylococcus aureus in community acquired pneumonia. Chest 2006; 130: 623.
25. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemimc influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: 962-970.
26. Chickering HT, Park JH. Staphylococcus aureus pneumonia. JAMA 1919; 72: 617-626.
27. Ede S, Davis GM, Holmes FH. Staphylococcic pneumonia. JAMA 1959; 170: 638-643.
28. Heimann HA. Primary staphylococcic pneumonia. JAMA 1933; 101: 514-520.
29. Hausmann W, Karlish AJ. Staphylococcal pneumonia in adults. BMJ 1956; 2: 845-547.
30. Gallis HA. Subacute staphylococcal pneumonia in renal transplant recipient. Am Rev Respir Dis 1975; 112: 109-112.
31. Watanakunakorn C. Bacteremic Staphylococcus aureus pneumonia. Scand J Infect Dis 1987; 19: 623-627.
32. Wiita RM, Cartwright RR, Davis JG. Staphylococcal pneumonia in adults: a review of 102 cases. AJR Am J Roentgenol 1961; 86: 1083-1091.
33. Bentley DW. Staphylococcal pneumonia: coping with a medical emergency. J Respir 1980; 1: 23-41.
34. Kaye MG, Fox MJ, Bartlett JG, et al. The clinical spectrum of Staphylococcus aureus pulmonary infection. Chest 1990; 97: 788-792.
35. Vidaur L, Planas K, Sierra R, et al. Ventilator-associated pneumonia. Impact of organisms on clinical resolution and medical resources utilization. Chest 2008; 133: 625-632.
36. Lode H. Best use of antibiotics in nosocomial pneumonia improving efficacy and limiting resistance. Eur Respir Rev 2007; 16: 31-32.
37. Rello J, Sole-Violan J, Sa-Borges M, et al. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit Care Med 2005; 33: 1983-1987.
38. Bradley SF. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 2005; 26: 643-649.
39. Healy CM, Hulten KG, Palazzi D, et al. Emergence of new strains of meticillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39: 1460-1466.
40. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by meticillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40: 100-107.
41. Dufour P, Gillet Y, Bes M, et al. Community-acquired meticillinresistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-824.
42. Kravitz GR, Dries DJ, Peterson ML, et al. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40: 941-947.
43. Hageman JC, Uyeki TM, Francis JS, et al. Severe communitya-cquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12: 894-899.
44. Frazee BW, Salz TO, Lambert L, et al. Fatal community-associated meticillin-resistant Staphylococcus aureus pneumonia in an immuno-competent young adult. Ann Emerg Med 2005; 46: 401-404.
45. Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 2005; 41: 583-590.
46. Kollef MH. Diagnosis of ventilator-associated pneumonia. N Engl J Med 2006; 355: 2691-2693.
47. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988; 138: 110-106.
48. Monecke S, Slickers P, Hotzel H, et al. Microarray-based characterisation of a Panton-Valentine leukocidin-positive community-acquired strain of meticillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006; 12: 718-728.
49. Monaco M, Antonucci R, Palenge P, et al. Meticillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis 2005; 11: 1647-1648.
50. Tronci M, Parisi G, Pantosti A, et al. CA-MRSA strain with decreased vancomycin susceptibility as a cause of serious invasive infection in an immunocompetent adolescent. 17th European Congress of Clinical Microbiology and Infectious Diseases. Munich, 31 March to 3 April, 2007. Abstract available from www. blackwellpublishing.com/eccmid17/abstract.asp?id=57394
51. Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton-Valentine leukociclin-positive community-acquired methicilin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005; 128: 2732-2738.